General Motors (NYSE:GM): Sterne Agee has raised its price target on General Motors’s shares to $50 from $46 in order to reflect the positive impact of the repurchase and conversion of its preferred stock, as well as the better-than-expected launch of its new full-size pickup trucks. The firm believes General Motors’s balance sheet remains strong, and the shares keep a Buy rating.
Micron (NASDAQ:MU): Bank of America Merrill Lynch continues to see an upside for Micron’s shares given the industry’s current supply constraints, the favorable competitive landscape, and the likelihood of positive fourth quarter results. Micron shares are Buy rated, and the price target for the shares has been raised to $20.50 from $18.
Ariad (NASDAQ:ARIA): Leerink believes there remains a place for Ariad’s leukemia drug Iclusig with patients in the salvage setting, despite continued cardiovascular toxicity findings. The firm thinks the benefit of Iclusig is likely to outweigh its risks, and the analyst keeps an Outperform rating on shares of Ariad, despite lowering its price target for the shares to $9 from $28.
Ultimate Software (NASDAQ:ULTI): Stephens checks indicate that Ultimate Software maintains solid momentum with both large and midsize customers following its new recruiting product refresh; the firm believes marketing visibility has created inbound interest and that the growth is sustainable. The firm reiterates its Overweight rating and raised its price target on Ultimate Software shares to $180 from $150.